新型粘弹性烧伤敷料:动态细胞与器官型皮肤模型研究
本研究开发了一种含海洋矿物复合物(MXC)的粘弹性急诊烧伤敷料,利用LabSkin三维全层人皮肤等效模型及体外细胞与分子分析进行评估。结果显示该敷料低致敏、可提升皮肤屏障功能与水合达24小时、应用时启动冷却并限制烧伤进展,且能调节炎症、促进愈合相关基因表达,可能减轻瘢痕。
要点
- 该敷料低致敏,可提升皮肤屏障功能并增加水合达24小时。
- 应用时启动冷却,限制持续烧伤效应,防止局部组织损伤与坏死。
- 在24和48小时调节愈合与纤维化基因,促进健康重塑表型。
核心结论
- 该含MXC的急诊烧伤敷料作为初级治疗有效且易用,提供冷却与水合环境,调节炎症并促进愈合。
- 该敷料促进健康重塑表型,可能减轻瘢痕,适用于院前、术前及资源有限环境。
研究设计与样本
- 开发一种饱和于大于90%半透明水基无菌无油凝胶、携带海洋矿物复合物(MXC)的急诊烧伤敷料。
- 使用LabSkin三维全层人皮肤等效模型,结合体外实时细胞分析(RTCA)、热分析和聚焦转录组阵列进行基因表达分析。
- 另进行体内分析评估该敷料对人皮肤的生物力学和生理效应。
主要发现
- 该敷料低致敏,改善皮肤屏障功能,增加水合达24小时。
- 应用时有效启动冷却,限制持续烧伤效应,防止局部组织损伤和坏死。
- 对原代人真皮细胞(角质形成细胞、成纤维细胞和微血管内皮细胞)的RTCA显示细胞张力、迁移、增殖和细胞间接触(屏障形成)功能改善。
- 定量基因谱分析支持生理和细胞功能发现,在24和48小时观察到伤口愈合和纤维化形成相关基因的有益相互调节。
临床怎么用
- 可作为烧伤初级治疗,提供冷却和水合环境,为专科二级烧伤创面管理做准备。
- 适用于院前、术前和资源有限环境。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Burn injuries are a major cause of morbidity and mortality worldwide. Despite advances in therapeutic strategies for the management of patients with severe burns, the sequelae are pathophysiologically profound, up to the systemic and metabolic levels. Management of patients with a severe burn injury is a long-term, complex process, with treatment dependent on the degree and location of the burn and total body surface area (TBSA) affected. In adverse conditions with limited resources, efficient triage, stabilisation, and rapid transfer to a specialised intensive care burn centre is necessary to provide optimal outcomes. This initial lag time and the form of primary treatment initiated, from injury to specialist care, is crucial for the burn patient. This study aims to investigate the efficacy of a novel visco-elastic burn dressing with a proprietary bio-stimulatory marine mineral complex (MXC) as a primary care treatment to initiate a healthy healing process prior to specialist care. METHODS: A new versatile emergency burn dressing saturated in a >90% translucent water-based, sterile, oil-free gel and carrying a unique bio-stimulatory marine mineral complex (MXC) was developed. This dressing was tested using LabSkin as a burn model platform. LabSkin a novel cellular 3D-dermal organotypic full thickness human skin equivalent, incorporating fully-differentiated dermal and epidermal components that functionally models skin. Cell and molecular analysis was carried out by in vitro Real-Time Cellular Analysis (RTCA), thermal analysis, and focused transcriptomic array profiling for quantitative gene expression analysis, interrogating both wound healing and fibrosis/scarring molecular pathways. In vivo analysis was also performed to assess the bio-mechanical and physiological effects of this novel dressing on human skin. RESULTS: This hybrid emergency burn dressing (EBD) with MXC was hypoallergenic, and improved the barrier function of skin resulting in increased hydration up to 24 h. It was demonstrated to effectively initiate cooling upon application, limiting the continuous burn effect and preventing local tissue from damage and necrosis. xCELLigence RTCA® on primary human dermal cells (keratinocyte, fibroblast and micro-vascular endothelial) demonstrated improved cellular function with respect to tensegrity, migration, proliferation and cell-cell contact (barrier formation) [1]. Quantitative gene profiling supported the physiological and cellular function finding. A beneficial quid pro quo regulation of genes involved in wound healing and fibrosis formation was observed at 24 and 48 h time points. CONCLUSION: Utilisation of this EBD + MXC as a primary treatment is an effective and easily applicable treatment in cases of burn injury, proving both a cooling and hydrating environment for the wound. It regulates inflammation and promotes healing in preparation for specialised secondary burn wound management. Moreover, it promotes a healthy remodelling phenotype that may potentially mitigate scarring. Based on our findings, this EBD + MXC is ideal for use in all pre-hospital, pre-surgical and resource limited settings.
引用
- Wallace RG, Kenealy MR, Brady AJ, et al. Development of dynamic cell and organotypic skin models, for the investigation of a novel visco-elastic burns treatment using molecular and cellular approaches. Burns. 2020. PMID: 32475797. doi:10.1016/j.burns.2020.04.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。